Completed
Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease
NCT00101946
- Conditions
- Crohn Disease, Crohn's Disease, Digestive System Diseases, +4 more
- Locations
-
- GSK Investigational Site Garden Grove, California, United States
- GSK Investigational Site Roseville, California, United States
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Topeka, Kansas, United States